I Antal

Author PubWeight™ 12.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In vitro food-drug interaction study: Which milk component has a decreasing effect on the bioavailability of ciprofloxacin? J Pharm Biomed Anal 2009 1.46
2 Fibrous dysplasia associated with intramuscular myxoma (Mazabraud's syndrome): a long-term follow-up of three cases. J Cancer Res Clin Oncol 1998 1.15
3 Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results. Int Orthop 2006 1.03
4 Schizophrenia: redox regulation and volume neurotransmission. Curr Neuropharmacol 2011 0.90
5 Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J Pharm Biopharm 2006 0.86
6 Mid-foot reconstruction following involvement of five bones by giant cell tumor. Skeletal Radiol 2000 0.84
7 Surgical treatment and prognostic factors in giant-cell tumor of bone. Acta Chir Orthop Traumatol Cech 2003 0.83
8 Potential application of Metolose in a thermoresponsive transdermal therapeutic system. Int J Pharm 2007 0.80
9 Development of spherical crystals of acetylsalicylic acid for direct tablet-making. Chem Pharm Bull (Tokyo) 2000 0.80
10 Calcitonin therapy of aneurysmal bone cysts. J Cancer Res Clin Oncol 1992 0.78
11 Visible light induced ocular delayed bioluminescence as a possible origin of negative afterimage. J Photochem Photobiol B 2011 0.78
12 New formulation of in situ gelling Metolose-based liquid suppository. Drug Dev Ind Pharm 2010 0.77
13 Functional outcome and life quality after endoprosthetic reconstruction following malignant tumours around the knee. Int Orthop 2005 0.77
14 Estimation of the number of biophotons involved in the visual perception of a single-object image: biophoton intensity can be considerably higher inside cells than outside. J Photochem Photobiol B 2010 0.76
15 [Clinical experiences of interval treatment with dermatologic agents containing urea]. Z Hautkr 1990 0.76
16 Comparison of the stability of different tablet formulations containing folic acid, vitamin B6 and B12. Pharmazie 2001 0.75
17 Formulation of controlled release drug preparations with antacid effect. Pharmazie 1996 0.75
18 [Results of limb-saving surgery and prognostic factors in patients with osteosarcoma]. Orv Hetil 2000 0.75
19 Limb saving surgery in bone tumours: experiences in Hungary. Acta Chir Hung 1994 0.75
20 The effect of oil as a dietary component on in vitro dissolution of an acid-labile drug. Pharmazie 2003 0.75
21 [Association of probably tuberculous uveitis with cataracta punctata cerulaea]. Ann Ocul (Paris) 1972 0.75
22 [Preformulation study of a controlled-release nitrofurantoin preparation. I]. Acta Pharm Hung 1987 0.75
23 [Dual fluorescence in situ hybridization analysis of synovial sarcoma]. Orv Hetil 1999 0.75
24 Examination and evaluation of surgical margins in bone tumours. Comparative pre- and postoperative CT and MR imaging. Int Orthop 1993 0.75
25 In vitro biopharmaceutical investigation of antacid activity in standard dissolution test apparatus. Acta Pharm Hung 1995 0.75
26 [Role of mass transfer processes in drug formulation]. Acta Pharm Hung 1996 0.75
27 [Evaluation of substrate-binder interfacial interactions]. Acta Pharm Hung 1998 0.75
28 [Preformulation study of controlled release nitrofurantoin preparations. 2]. Acta Pharm Hung 1990 0.75
29 [Results of using bone cement and phenol lavage in the surgical management of giant cell bone tumors]. Magy Traumatol Orthop Helyreallito Seb 1992 0.75
30 Effect of particle size and coating level on the diffuse reflectance of wax matrices. J Pharm Pharmacol 1998 0.75
31 [Replacement of the atrophied bladder with the sigmoid]. Orv Hetil 1965 0.75
32 Quantitative estimation of film forming polymer-plasticizer interactions by the Lorentz-Lorenz Law. Int J Pharm 2006 0.75
33 [10,000 case treated with accumulated electroshock combined with relaxant therapy]. Orv Hetil 1967 0.75
34 Pharmaceutical application of thermoresponsive materials. J Control Release 2005 0.75
35 [Pruritic urticarial papules and plaques in pregnancy]. Z Hautkr 1990 0.75
36 [Modification of drug release with application of pharmaceutical technological methods]. Acta Pharm Hung 1999 0.75
37 Evaluation of different mathematical methods describing drug liberation from new, "soft-patch" type matrix systems. Pharm Dev Technol 1999 0.75